Skip to main content
Top
Published in: Tumor Biology 10/2016

01-10-2016 | Original Article

IQGAP1 gene silencing induces apoptosis and decreases the invasive capacity of human hepatocellular carcinoma cells

Authors: Khairy MA Zoheir, Ahmed A. Abd-Rabou, Gamaleldin I Harisa, Ashok Kumar, Sheikh Fayaz Ahmad, Mushtaq Ahmad Ansari, Adel R Abd-Allah

Published in: Tumor Biology | Issue 10/2016

Login to get access

Abstract

IQ motif-containing GTPase-activating proteins (IQGAPs) belong to a conserved family, and they are involved in various intracellular processes. IQGAP1 is expressed in all cells, while IQGAP2 and IQGAP3 are mainly expressed in hepatic cells. IQGAP1 has been suggested to be an oncogene, while IQGAP2 is considered a tumor-suppressor gene. However, the relationship between RAS family genes and IQGAP genes remains unclear. We recently demonstrated this interaction in a chemically induced mouse liver cancer. In this study, IQGAP1 expression was partially silenced in human hepatocellular carcinoma (HepG2) cells. We investigated the impact of IQGAP1 silencing on the interactions of IQGAP and RAS with several apoptotic proteins, including caspase-3 (CASP3), BCL2-associated X protein (BAX), and B-cell leukemia/lymphoma 2 (BCL2). Additionally, we investigated the effects of the interactions of these genes on cell viability, proliferation, apoptosis, and invasive capacity. IQGAP1 siRNA-treated HepG2 cells showed lower invasive capacity than the control cells, and this reduction was time- and vector concentration-dependent. In addition, IQGAP1 silencing resulted in significantly lower IQGAP1 level and subsequently higher IQGAP2 and IQGAP3 expression in HepG2 cells than in the control. Flow cytometry analyses indicated that the silencing of IQGAP1 can induce early and late apoptosis in HepG2 cells. Additionally, IQGAP2, IQGAP3, CASP3, and BAX were upregulated whereas IQGAP1 and BCL2 were downregulated in the siRNA-treated cells. Furthermore, we observed that the mRNA levels of HRAS, KRAS, NRAS, and MRAS decreased upon IQGAP1 silencing. These findings indicate that IQGAP1 potentially regulates the expression of IQGAP and RAS gene families and demonstrate its regulatory role in the apoptotic network. Taken together, our findings suggest that IQGAP1 silencing plays crucial roles in the apoptosis of HepG2 cells and lowers their proliferative and invasive capacities.
Literature
1.
go back to reference Bernards A. GAPs galore! A survey of putative Ras superfamily GTPase activating proteins in man and drosophila. Biochim Biophys Acta. 2003;1603:47–82.PubMed Bernards A. GAPs galore! A survey of putative Ras superfamily GTPase activating proteins in man and drosophila. Biochim Biophys Acta. 2003;1603:47–82.PubMed
2.
go back to reference Chen F, Zhu H, Zhou L, Wu S, Wang J, Chen Z. IQGAP1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation by Akt activation. EXPERIMENTAL and MOLECULAR MEDICINE. July 2010;42(7):477–83. Chen F, Zhu H, Zhou L, Wu S, Wang J, Chen Z. IQGAP1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation by Akt activation. EXPERIMENTAL and MOLECULAR MEDICINE. July 2010;42(7):477–83.
3.
go back to reference Fukata M, Nakagawa M, Kaibuchi K. Roles of rho-family GTPases in cell polarisation and directional migration. Curr Opin Cell Biol. 2003;15(5):590–7.CrossRefPubMed Fukata M, Nakagawa M, Kaibuchi K. Roles of rho-family GTPases in cell polarisation and directional migration. Curr Opin Cell Biol. 2003;15(5):590–7.CrossRefPubMed
6.
go back to reference Brown MD, Sacks DB. IQGAP1 in cellular signaling: bridging the gap. Trends Cell Biol. 2006;16(5):242–9.CrossRefPubMed Brown MD, Sacks DB. IQGAP1 in cellular signaling: bridging the gap. Trends Cell Biol. 2006;16(5):242–9.CrossRefPubMed
7.
go back to reference Schmidt VA, Chiariello CS, Capilla E, Miller F, Bahou WF. Development of hepatocellular carcinoma in Iqgap2 deficient mice is IQGAP1 dependent. Mol Cell Biol. 2008;28(5):1489–502.CrossRefPubMedPubMedCentral Schmidt VA, Chiariello CS, Capilla E, Miller F, Bahou WF. Development of hepatocellular carcinoma in Iqgap2 deficient mice is IQGAP1 dependent. Mol Cell Biol. 2008;28(5):1489–502.CrossRefPubMedPubMedCentral
8.
go back to reference Schmidt VA, Scudder L, Devoe CE, Bernards A, Cupit LD, Bahou WF. IQGAP2 functions as a GTP-dependent effector protein in thrombin-induced platelet cytoskeletal reorganization. Blood. 2003;101(8):3021–8.CrossRefPubMed Schmidt VA, Scudder L, Devoe CE, Bernards A, Cupit LD, Bahou WF. IQGAP2 functions as a GTP-dependent effector protein in thrombin-induced platelet cytoskeletal reorganization. Blood. 2003;101(8):3021–8.CrossRefPubMed
9.
go back to reference Wang S, Watanabe T, Noritake J, Fukata M, Yoshimura T, Itoh N, Harada T, Nakagawa M, Matsuura Y, Arimura N, et al. IQGAP3, a novel effector of Rac1 and Cdc42, regulates neurite outgrowth. J Cell Sci. 2007;120(4):567–77.CrossRefPubMed Wang S, Watanabe T, Noritake J, Fukata M, Yoshimura T, Itoh N, Harada T, Nakagawa M, Matsuura Y, Arimura N, et al. IQGAP3, a novel effector of Rac1 and Cdc42, regulates neurite outgrowth. J Cell Sci. 2007;120(4):567–77.CrossRefPubMed
10.
go back to reference Briggs MW, Sacks DB. IQGAP proteins are integral components of cytoskeletal regulation EMBO rep. 2003;4:571–4. Briggs MW, Sacks DB. IQGAP proteins are integral components of cytoskeletal regulation EMBO rep. 2003;4:571–4.
11.
go back to reference White CD, Brown MD, Sacks DB IQGAPs in cancer: a family of scaffold proteins underlying tumorigenesis. FEBS Lett 2009;583:1817–1824 White CD, Brown MD, Sacks DB IQGAPs in cancer: a family of scaffold proteins underlying tumorigenesis. FEBS Lett 2009;583:1817–1824
12.
go back to reference Zoheir KMA, Abd-Rabou AA, Harisa GI, Ashour AE, Ahmad SF, Attia SM, et al. Gene expression of IQGAPs and Ras families in an experimental mouse model for hepatocellular carcinoma: a mechanistic study of cancer progression. International journal of clinical and experimental pathology. 2015;8(8):8821.PubMedPubMedCentral Zoheir KMA, Abd-Rabou AA, Harisa GI, Ashour AE, Ahmad SF, Attia SM, et al. Gene expression of IQGAPs and Ras families in an experimental mouse model for hepatocellular carcinoma: a mechanistic study of cancer progression. International journal of clinical and experimental pathology. 2015;8(8):8821.PubMedPubMedCentral
13.
go back to reference Johnson M, Sharma M, Henderson BR. IQGAP1 regulation and roles in cancer cellular signalling. 2009;21:1471–8. Johnson M, Sharma M, Henderson BR. IQGAP1 regulation and roles in cancer cellular signalling. 2009;21:1471–8.
14.
go back to reference Jadeski L, Mataraza JM, Jeong HW, Li Z, Sacks DB. IQGAP1 stimulates proliferation and enhances tumorigenesis of human breast epithelial cells. J Biol Chem 2008;283: 1008–1017 Jadeski L, Mataraza JM, Jeong HW, Li Z, Sacks DB. IQGAP1 stimulates proliferation and enhances tumorigenesis of human breast epithelial cells. J Biol Chem 2008;283: 1008–1017
15.
go back to reference Galuppo R, Maynard E, Shah M, Daily MF, Chen C, Spear BT, Gedaly R. Synergistic inhibition of HCC and liver cancer stem cell proliferation by targeting RAS/RAF/MAPK and WNT/β-catenin pathways. Anticancer Res. 2014;34:1709–14.PubMed Galuppo R, Maynard E, Shah M, Daily MF, Chen C, Spear BT, Gedaly R. Synergistic inhibition of HCC and liver cancer stem cell proliferation by targeting RAS/RAF/MAPK and WNT/β-catenin pathways. Anticancer Res. 2014;34:1709–14.PubMed
16.
go back to reference Kim Y, Sills RC, Houle CD. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver. Toxicol Pathol. 2005;33:175–80.CrossRefPubMed Kim Y, Sills RC, Houle CD. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver. Toxicol Pathol. 2005;33:175–80.CrossRefPubMed
17.
go back to reference Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 2002;31:339–46.CrossRefPubMed Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 2002;31:339–46.CrossRefPubMed
18.
go back to reference Fire A et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391:806–11.CrossRefPubMed Fire A et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391:806–11.CrossRefPubMed
19.
go back to reference Elbashir SM et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494–8.CrossRefPubMed Elbashir SM et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494–8.CrossRefPubMed
20.
21.
go back to reference Morrissey DV et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nature Biotech. 2005;23:1002–7.CrossRef Morrissey DV et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nature Biotech. 2005;23:1002–7.CrossRef
22.
go back to reference Okumura A, Pitha PM, Harty RN. ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc Natl Acad Sci U S A. 2008;105:3974–9.CrossRefPubMedPubMedCentral Okumura A, Pitha PM, Harty RN. ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc Natl Acad Sci U S A. 2008;105:3974–9.CrossRefPubMedPubMedCentral
23.
go back to reference Ptasznik A, Nakata Y, Kalota A, Emerson SG, Gewirtz AM. Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1+ leukemia cells. Nature Med. 2004;10:1187–9.CrossRefPubMed Ptasznik A, Nakata Y, Kalota A, Emerson SG, Gewirtz AM. Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1+ leukemia cells. Nature Med. 2004;10:1187–9.CrossRefPubMed
24.
go back to reference Kim SH, Jeong JH, Lee SH, Kim SW, Park TG. Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J Control Release. 2008;129:107–16.CrossRefPubMed Kim SH, Jeong JH, Lee SH, Kim SW, Park TG. Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J Control Release. 2008;129:107–16.CrossRefPubMed
25.
go back to reference Xia C-F, Zhang Y, Zhang Y, Boado R, Pardridge W. Intravenous siRNA of brain cancer with receptor targeting and avidin–biotin technology. Pharm Res. 2007;24:2309–16.CrossRefPubMed Xia C-F, Zhang Y, Zhang Y, Boado R, Pardridge W. Intravenous siRNA of brain cancer with receptor targeting and avidin–biotin technology. Pharm Res. 2007;24:2309–16.CrossRefPubMed
26.
go back to reference Dong P.X., Jia N., Xu Z.J, Liu Y.T., Li D.J, Feng Y.J., J. Exp. Clin. Cancer Res. 27 (2008) Dong P.X., Jia N., Xu Z.J, Liu Y.T., Li D.J, Feng Y.J., J. Exp. Clin. Cancer Res. 27 (2008)
28.
go back to reference Yamaoka-Tojo M et al. IQGAP1 a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species-dependent endothelial migration and proliferation. Circ Res. 2004;95:276–83.CrossRefPubMed Yamaoka-Tojo M et al. IQGAP1 a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species-dependent endothelial migration and proliferation. Circ Res. 2004;95:276–83.CrossRefPubMed
29.
go back to reference Meyer RD, Sacks DB, Rahimi N. IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis. PLoS One. 2008;3:e3848–58.CrossRefPubMedPubMedCentral Meyer RD, Sacks DB, Rahimi N. IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis. PLoS One. 2008;3:e3848–58.CrossRefPubMedPubMedCentral
30.
go back to reference Liang C, Park AY, Guan J. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007;2:329–33.CrossRefPubMed Liang C, Park AY, Guan J. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007;2:329–33.CrossRefPubMed
31.
go back to reference Dong P, Nabeshima K, Nishimura N, Kawakami T, Hachisuga T, Kawarabayashi T, Iwasaki H. Overexpression and diffuse expression pattern of IQGAP1 at invasion fronts are independent prognostic parameters in ovarian carcinomas. Cancer Lett. 2006;243:120–7.CrossRefPubMed Dong P, Nabeshima K, Nishimura N, Kawakami T, Hachisuga T, Kawarabayashi T, Iwasaki H. Overexpression and diffuse expression pattern of IQGAP1 at invasion fronts are independent prognostic parameters in ovarian carcinomas. Cancer Lett. 2006;243:120–7.CrossRefPubMed
32.
go back to reference Nabeshima K, Shimao Y, Inoue T, Koono M. Immunohistochemical analysis of IQGAP1 expression in human colorectal carcinomas: its overexpression in carcinomas and association with invasion fronts. Cancer Lett. 2002;176:101–9.CrossRefPubMed Nabeshima K, Shimao Y, Inoue T, Koono M. Immunohistochemical analysis of IQGAP1 expression in human colorectal carcinomas: its overexpression in carcinomas and association with invasion fronts. Cancer Lett. 2002;176:101–9.CrossRefPubMed
33.
go back to reference Walch A, Seidl S, Hermannstadter C, et al. Combined analysis of Rac1, IQGAP1, Tiam1 and E-cadherin expression in gastric cancer. Mod Pathol. 2008;21:544–52.CrossRefPubMed Walch A, Seidl S, Hermannstadter C, et al. Combined analysis of Rac1, IQGAP1, Tiam1 and E-cadherin expression in gastric cancer. Mod Pathol. 2008;21:544–52.CrossRefPubMed
34.
go back to reference Jin SH, Akiyama Y, Fukamachi H, et al. IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells. Int J Cancer. 2008;122:1040–6.CrossRefPubMed Jin SH, Akiyama Y, Fukamachi H, et al. IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells. Int J Cancer. 2008;122:1040–6.CrossRefPubMed
35.
go back to reference Xie Y, Yan J, Cutz JC, et al. IQGAP2, a candidate tumour suppressor of prostate tumorigenesis. Biochim Biophys Acta. 2012;1822:875–84.CrossRefPubMed Xie Y, Yan J, Cutz JC, et al. IQGAP2, a candidate tumour suppressor of prostate tumorigenesis. Biochim Biophys Acta. 2012;1822:875–84.CrossRefPubMed
36.
go back to reference Schmidt VA. Watch the GAP: emerging roles for IQ motif-containing GTPase-activating proteins IQGAPs in hepatocellular carcinoma. Int J Hepatol. 2012;2012:958673.CrossRefPubMedPubMedCentral Schmidt VA. Watch the GAP: emerging roles for IQ motif-containing GTPase-activating proteins IQGAPs in hepatocellular carcinoma. Int J Hepatol. 2012;2012:958673.CrossRefPubMedPubMedCentral
37.
go back to reference Zhou J, et al. Quantitative proteomic analysis of HepG2 cells treated with quercetin suggests IQGAP1 is involved in quercetin-induced regulation of cell proliferation and migration. Omics. 2009. Zhou J, et al. Quantitative proteomic analysis of HepG2 cells treated with quercetin suggests IQGAP1 is involved in quercetin-induced regulation of cell proliferation and migration. Omics. 2009.
39.
go back to reference Gnatenko DV, Xu X, Zhu W, Schmidt VA. Transcript profiling identifies iqgap2(−/−) mouse as a model for advanced human hepatocellular carcinoma. PLoS One. 2013;8:e71826.CrossRefPubMedPubMedCentral Gnatenko DV, Xu X, Zhu W, Schmidt VA. Transcript profiling identifies iqgap2(−/−) mouse as a model for advanced human hepatocellular carcinoma. PLoS One. 2013;8:e71826.CrossRefPubMedPubMedCentral
40.
go back to reference Brill S, Li S, Lyman CW, et al. The Ras GTPase-activating-protein-related human protein IQGAP2 harbors a potential actin binding domain and interacts with calmodulin and Rho family GTPases. Mol Cell Biol. 1996;16:4869–78.CrossRefPubMedPubMedCentral Brill S, Li S, Lyman CW, et al. The Ras GTPase-activating-protein-related human protein IQGAP2 harbors a potential actin binding domain and interacts with calmodulin and Rho family GTPases. Mol Cell Biol. 1996;16:4869–78.CrossRefPubMedPubMedCentral
41.
go back to reference Hart MJ, Callow MG, Souza B, Polakis P. IQGAP1, a calmodulin-binding protein with a RasGAP-related domain, is a potential effector for cdc42Hs. EMBO J. 1996;15:2997–3005.PubMedPubMedCentral Hart MJ, Callow MG, Souza B, Polakis P. IQGAP1, a calmodulin-binding protein with a RasGAP-related domain, is a potential effector for cdc42Hs. EMBO J. 1996;15:2997–3005.PubMedPubMedCentral
42.
go back to reference McCallum SJ, WJ W, Cerione RA. Identification of a putative effector for Cdc42Hs with high sequence similarity to the RasGAP-related protein IQGAP1 and a Cdc42Hs binding partner with similarity to IQGAP2. J Biol Chem. 1996;271:21732–7.CrossRefPubMed McCallum SJ, WJ W, Cerione RA. Identification of a putative effector for Cdc42Hs with high sequence similarity to the RasGAP-related protein IQGAP1 and a Cdc42Hs binding partner with similarity to IQGAP2. J Biol Chem. 1996;271:21732–7.CrossRefPubMed
43.
go back to reference Joyal JL, Annan RS, Ho YD, et al. Calmodulin modulates the interaction between IQGAP1 and Cdc42. Identification of IQGAP1 by nanoelectrospray tandem mass spectrometry. J Biol Chem. 1997;272:15419–25.CrossRefPubMed Joyal JL, Annan RS, Ho YD, et al. Calmodulin modulates the interaction between IQGAP1 and Cdc42. Identification of IQGAP1 by nanoelectrospray tandem mass spectrometry. J Biol Chem. 1997;272:15419–25.CrossRefPubMed
44.
go back to reference Van Hengel J, D’Hooge P, Hooghe B, et al. Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver. Gastroenterology. 2008;134:781–92.CrossRefPubMed Van Hengel J, D’Hooge P, Hooghe B, et al. Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver. Gastroenterology. 2008;134:781–92.CrossRefPubMed
Metadata
Title
IQGAP1 gene silencing induces apoptosis and decreases the invasive capacity of human hepatocellular carcinoma cells
Authors
Khairy MA Zoheir
Ahmed A. Abd-Rabou
Gamaleldin I Harisa
Ashok Kumar
Sheikh Fayaz Ahmad
Mushtaq Ahmad Ansari
Adel R Abd-Allah
Publication date
01-10-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 10/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-016-5283-8

Other articles of this Issue 10/2016

Tumor Biology 10/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine